KYPROLIS (Onyx Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the KYPROLIS drug offered from Onyx Pharmaceuticals, Inc.. This Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Onyx Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | carfilzomib |
| SUBSTANCE NAME: | CARFILZOMIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-07-20 |
| END MARKETING DATE: | 0000-00-00 |
KYPROLIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | KYPROLIS from Onyx Pharmaceuticals, Inc. |
| LABELER NAME: | Onyx Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 60(mg/30mL) |
| START MARKETING DATE: | 2012-07-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76075-101_ae5a15c4-8a7b-4a69-b87d-73b80e57033a |
| PRODUCT NDC: | 76075-101 |
| APPLICATION NUMBER: | NDA202714 |
Other CARFILZOMIB Pharmaceutical Manufacturers / Labelers:
